Latest 5 articles from heartwire
- Long-term, but small, PASSION and DEDICATION studies raise concern about DES in STEMI
Mar 16, 2010 18:15 EDT - PLATO CABG analysis confuses cardiologists
Mar 16, 2010 17:15 EDT - Patency for radial-artery no better than saphenous-vein grafts at one year
Mar 16, 2010 16:15 EDT - Warfarin genotyping reduces hospitalizations
Mar 16, 2010 16:00 EDT - Finally final? New STICH analysis finds no subset that benefits from ventricular reconstruction
Mar 16, 2010 14:45 EDT
Low-dose aspirin for primary prevention
Posted Jun 17, 2009
at 02:03 PM, EDT
by Eric Topol
A new meta-analysis questions the use of low-dose aspirin for the prevention of cardiovascular events. Given its current wide use, these findings are important and have far-reaching consequences. What are your thoughts?
See:
Meta-analysis questions use of aspirin in primary prevention
Previous postsBillets précédents
Should we loosen up on ventricular rate control?
No commentsAucun commentaire |
Posted Mar 16, 2010
at 11:20 AM, EDT by Eric Publié le 03.16.2010 à 11h20 par Eric
at 11:20 AM, EDT by Eric Publié le 03.16.2010 à 11h20 par Eric
Mitral-clip in EVEREST II: A step forward
No commentsAucun commentaire |
Posted Mar 15, 2010
at 11:30 PM, EDT by Eric Publié le 03.15.2010 à 23h30 par Eric
at 11:30 PM, EDT by Eric Publié le 03.15.2010 à 23h30 par Eric
Mobile pocket echo device: Revolutionizing medicine
32 comments32 commentaires |
Posted Feb 05, 2010
at 12:40 PM, EDT by Eric Publié le 02.05.2010 à 12h40 par Eric
at 12:40 PM, EDT by Eric Publié le 02.05.2010 à 12h40 par Eric
Lipoprotein(a): a causal factor for coronary disease
3 comments3 commentaires |
Posted Jan 07, 2010
at 10:30 AM, EDT by Eric Publié le 01.07.2010 à 10h30 par Eric
at 10:30 AM, EDT by Eric Publié le 01.07.2010 à 10h30 par Eric
Twitter: A place in the medical world?
5 comments5 commentaires |
Posted Dec 16, 2009
at 10:30 AM, EDT by Eric Publié le 12.16.2009 à 10h30 par Eric
at 10:30 AM, EDT by Eric Publié le 12.16.2009 à 10h30 par Eric
Also from theheart.org
Blogs I read
Who's talking
|
Eric J Topol MD
Director, Scripps Translational Science Institute The Gary and Mary West Chair of Innovative Medicine Chief Academic Officer, Scripps Health La Jolla, CA |














CommentsCommentaires
Aloha!
What recommendations would you recommend?
As a non-academic clinical physician, are there objective findings, on physical exam, or lab tests which i might be able to utilize which would allow me to make the most prudent recommendation?
Mahalo for your video presentation.
Madhup Joshi, MD
Dear Doctor,
It was nice to hear your vidio.I am a retired Cardiac nethesiologist and keen to get in touch the latest about CVD prevention and managements.
Have a good day.
Dr K S Johar,MBBS,MD
Any therapy is associated with risk.
Low dose aspirin for prevention of heart events in patients with atherosclerosis is clearly of value as the risk of death from MI is much greater than risk of death from bleeding.
Low dose aspirin in subjects with no atherosclerosis is unlikely to have any value in preventing a heart attack because the individual is at such low risk. The small possibility of a major bleeding event overshadows the immeasurably small risk of MI in atherosclerotisis free individuals.
I see this as yet another in a very long line of reasons that we should be doing atherosclerosis imaging. The presence of any calcium within coronary vessels increases one's risk of an MI by 3 times that risk predicted by conventional risk factors (MESA), a score >100 increases risk 7 times. This should be a clear indication for low dose aspirin (plus other medical and lifestyle interventions).
The absence of calcium in coronary vessels by EBT is associated with a 10 year risk of 1%. With this level of risk, aspirin can only cause harm as you would need to put 3,000 subjects on ASA for ten years to maybe prevent one heart attack, or 3,000 subjects for 30 years to prevent one fatal heart attack. The risk of dying from complications of ASA over 90,000 patient years exceeds 1!
Conventional risk factors have been shown to be entirely too weak and unreliable to base therapy decisions upon, especially when these interventions have risks. Primum non nocere
I agree 100% to to your idea - Prumum non nocere